Get started
Twist Bioscience CorporationTwist Bioscience CorporationTwist Bioscience Corporation

Twist Bioscience Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

TWST chart


Full chart

TWST upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.87 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.60 USD
Net income (FY)
‪−208.73 M‬ USD
Revenue (FY)
‪312.97 M‬ USD
Shares float
‪56.14 M‬
Beta (1Y)
3.64

Employees


Employees (FY)
923
Change (1Y)
+4 +0.44%
Revenue / Employee (1Y)
‪339.08 K‬ USD
Net income / Employee (1Y)
‪−226.14 K‬ USD

About Twist Bioscience Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Emily Marine Leproust
Website
twistbioscience.com
Headquarters
San Francisco
Founded
2013
FIGI
BBG006KDCHJ4
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TWST news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TWST is 48.40 USD — it has decreased by −0.06% in the past 24 hours. Watch Twist Bioscience Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Twist Bioscience Corporation stocks are traded under the ticker TWST.
TWST stock has fallen by −6.29% compared to the previous week, the month change is a 23.47% rise, over the last year Twist Bioscience Corporation has showed a 39.00% increase.
We've gathered analysts' opinions on Twist Bioscience Corporation future price: according to them, TWST price has a max estimate of 62.00 USD and a min estimate of 35.00 USD. Watch TWST chart and read a more detailed Twist Bioscience Corporation stock forecast: see what analysts think of Twist Bioscience Corporation and suggest that you do with its stocks.
TWST reached its all-time high on Jan 21, 2021 with the price of 214.07 USD, and its all-time low was 11.46 USD and was reached on May 2, 2023. View more price dynamics on TWST chart.
See other stocks reaching their highest and lowest prices.
TWST stock is 5.01% volatile and has beta coefficient of 3.64. Track Twist Bioscience Corporation stock price on the chart and check out the list of the most volatile stocks — is Twist Bioscience Corporation there?
Today Twist Bioscience Corporation has the market capitalization of ‪2.87 B‬, it has decreased by −3.71% over the last week.
Yes, you can track Twist Bioscience Corporation financials in yearly and quarterly reports right on TradingView.
Twist Bioscience Corporation is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
TWST earnings for the last quarter are −0.59 USD per share, whereas the estimation was −0.71 USD resulting in a 17.35% surprise. The estimated earnings for the next quarter are −0.63 USD per share. See more details about Twist Bioscience Corporation earnings.
Twist Bioscience Corporation revenue for the last quarter amounts to ‪84.71 M‬ USD, despite the estimated figure of ‪82.71 M‬ USD. In the next quarter, revenue is expected to reach ‪86.97 M‬ USD.
TWST net income for the last quarter is ‪−34.66 M‬ USD, while the quarter before that showed ‪−85.57 M‬ USD of net income which accounts for 59.50% change. Track more Twist Bioscience Corporation financial stats to get the full picture.
No, TWST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 923.00 employees. See our rating of the largest employees — is Twist Bioscience Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Twist Bioscience Corporation EBITDA is ‪−144.47 M‬ USD, and current EBITDA margin is −46.16%. See more stats in Twist Bioscience Corporation financial statements.
Like other stocks, TWST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Twist Bioscience Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Twist Bioscience Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Twist Bioscience Corporation stock shows the buy signal. See more of Twist Bioscience Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.